S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

Authors :: Monika Fisher
Colleen S. Kraft
Jeff S. Bullock
Sarah K. McGill
Josh Silva
Ari Grinspan
Nicholas W. Van Hise
John Pullman
Thomas J. Louie
Darrell S. Pardi
Colleen R. Kelly
Michael Silverman
Susy Hota
Zain Kassam
Richard Nathan
Ian Davis
Shrish Budree
Eugene F. Yen
Najwa El-Nachef
Sahil Khanna
Thomas J. Borody
Robert Orenstein
Misra Bg
Jessica R. Allegretti
Ylaine Gerardin
Source :: American Journal of Gastroenterology. 116:S63-S63
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Gastroenterology
Placebo-controlled study
Medicine
Microbiome
C difficile
business

Full Text Access

Tools